propyl (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-tris(3-aminopropanoyloxy)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: propyl (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-tris(3-aminopropanoyloxy)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate
• 化学式: C₃₆H₆₁N₃O₈
• 分子量: 663.9
• InChiKey: GAWRIYLEUPCXPC-BPMNBXBBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  47
• 可旋转键数：
  19
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  183
• 氢给体数：
  3
• 氢受体数：
  11

文献信息

• METHODS FOR REDUCING CELLULAR PROLIFERATION AND TREATING CERTAIN DISEASES
  申请人：Genberg Carl

  公开号：US20140194401A1

  公开（公告）日：2014-07-10

  Disclosed herein are methods of treating cancer and/or reducing cellular proliferation in a patient, comprising identifying a patient in need of treatment and administering a therapeutically effective amount of at least one cationic steroid antimicrobial (CSA), or a pharmaceutically acceptable salt thereof. Kits comprising such compositions and instructions on such methods are also contemplated herein.
• US9943529B2
  申请人：——

  公开号：US9943529B2

  公开（公告）日：2018-04-17